UBS Webcast | FDA Final Rule on Lab Developed Tests (LDTs)
Hosted by Kevin Caliendo, Senior Analyst for US Healthcare Distribution and HCIT at UBS, this one-hour audiocast focuses on the April 29, 2024, announcement of FDA’s final rule on LDTs.
The final rule differed in key ways from what the FDA initially posted at the end of 2023, but leaves many questions still unanswered. On this call, Lâle and Kyle field questions from UBS analysts on how to interpret the rule, as well as potential short- and long- term implications for the laboratory diagnostics industry.
